Abstract
Cogan or Cogan’s syndrome is a rare systemic inflammatory disease characterized by tinnitus, vertigo, hearing loss, and ocular inflammation. Aside from the effects on the sensory organs, the disease can manifest as a systemic vasculitis with a 10 % mortality rate. The most common treatments are high-dose corticosteroids.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cogan DG. Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms. Arch Ophthalmol. 1945;33:144–9.
Haynes BF, Kaiser-Kupfer MI, Mason P, Fauci AS. Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine. 1980;59:426–41.
Mogan RF, Baumgartner CJ. Meniere’s disease complicated by recurrent interstitial keratitis: excellent result following cervical ganglionectomy. West J Surg. 1934;42:628–31.
Kessel A, Vadasz Z, Toubi E. Autoimmun Rev. 2014;13:351–4.
Lee LY, Akhtar MM, Kirresh O, Gibson T. Interstitial keratitis and sensorineural hearing loss as a manifestation of rheumatoid arthritis: clinical lessons from a rare complication. BMJ Case Rep. 2012;2012.
Ghadban R, Couret M, Zenone T. Efficacy of infliximab in Cogan’s syndrome. J Rheumatol. 2008;35:2456–8.
Vollertsen RS, McDonald TJ, Younge BR, et al. Cogan’s syndrome: 18 cases and a review of the literature. Mayo Clin Proc. 1986;61:344–61.
Gluth MB, Baratz KH, Matteson EL, Driscoll CLW. Cogan syndrome: a retrospective review of 60 patients throughout a half century. Mayo Clin Proc. 2006;81:483–8.
Cundiff J, Kansal S, Kumar A, et al. Cogan’s syndrome: a cause of progressive hearing deafness. Am J Otolaryngol. 2006;27:68–70.
Vasileiadis I, Stratoudaki R, Karakostas E. Int J Pediatr Otorhinolaryngol. 2012;76:601–5.
Hautefort C, Loundon N, Montchilova M, et al. Mycophenolate mofetil as a treatment of steroid dependent Cogan’s syndrome in childhood. Int J Pediatr Otorhinolaryngol. 2009;73:1477–9.
Pagnini I, Zannin ME, Vittadello F, et al. Clinical features and outcome of Cogan syndrome. J Pediatr. 2012;160(303–307):e1.
Greco A, Gallo A, Fusconi M, et al. Autoimmun Rev. 2013;12:396–400.
Lepur D, Vranjican Z, Himbele J, et al. Chlamydia pneumoniae infection as a trigger for a Cogan’s syndrome. J Infect. 2006;52:223–6.
Sugimoto K, Miyazawa T, Nishi H, et al. Childhood Cogan syndrome with aortitis and anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Pediatr Rheumatol. 2014;12:1–5.
Nolte KW, Hans VJ, Schattenfroh C, et al. Perineurial cells filled with collagen in “atypical” Cogan’s syndrome. Acta Neuropathol. 2007;115:589–96.
Darougar S, John AC, Viswalingam M, et al. Isolation of Chlamydia psittaci from a patient with interstitial keratitis and uveitis associated with otological and cardiovascular lesions. Br J Ophthalmol. 1978;62:709–14.
Tayer-Shifman OE, Ilan O, Tovi H, Tal Y. Cogan’s syndrome—clinical guidelines and novel therapeutic approaches. Clin Rev Allerg Immunol. 2014.
McCallum RM, Haynes BF. Ocular infection and immunity. In: Pepose JS, Holland GN, editors. Mosby year book. St. Louis, MO; 1996. p. 446–59.
Bisdas TE, Teebken OE, Wilhelmi M, et al. Surgical treatment of a thoracoabdominal aneurysm in Cogan’s syndrome. ATS. 2009;88:1668–70.
Lunardi C, Bason C, Leandri M, et al. Autoantibodies to inner ear and endothelial antigens in Cogan’s syndrome. Lancet. 2002;360:915–21.
Grasland A. Typical and atypical Cogan’s syndrome: 32 cases and review of the literature. Rheumatology. 2004;43:1007–15.
Georgakopoulos CD, Makri OE, Exarchou AM, Pharmakakis N. Atypical Cogan’s syndrome presenting as bilateral endogenous endophthalmitis. Clin Exp Optom. 2012;97:87–9.
Deliveliotou A, Moustakarias T, Argeitis J, et al. Successful full-term pregnancy in a woman with Cogan’s syndrome: a case report. Clin Rheumatol. 2007;26:2181–3.
Currie C, Wax JR, Pinette MG, et al. Cogan’s syndrome complicating pregnancy. J Matern Fetal Neonatal Med. 2014;22:928–30.
Singh P, Gupta M, Lehl SS, Singh K. Cogan’s syndrome: achievement of complete resolution of auditory deficit with steroids. BMJ Case Rep. 2013;2013.
Best C, Thömke F, Hitzler W, Dieterich M. Immunol Lett. 2013;150:87–8.
Branislava I, Marijana T, Nemanja D, et al. Atypical Cogan’s syndrome associated with coronary disease. Chin Med J Beijing. 2011;124:3192.
Pysden KS, Long V, Ferrie CD. Leeds teaching hospitals NHS trust. Cogan’s syndrome: a rare cause of meningoencephalitis. J Child Neurol. 2009;24:753–7.
Tomita M, Chiba A, Inoue N, et al. Cogan syndrome presenting after uneventful laser in situ keratomileusis. J Cataract Refract Surg. 2013;39:1260–6.
Ndiaye IC, Rassi SJ, Wiener-Vacher SR. Cochleovestibular impairment in pediatric Cogan’s syndrome. Pediatrics. 2002;109:E38.
Fricker M, Baumann A, Wermelinger F, et al. A novel therapeutic option in Cogan diseases? TNF-α blockers. Rheumatol Int. 2006;27:493–5.
Murphy G, Sullivan MO, Shanahan F, et al. Cogan’s syndrome: present and future directions. Rheumatol Int. 2009;29:1117–21.
Podder S, Shepherd RC. Cogan’s syndrome: a rare systemic vasculitis. Arch Dis Child. 1994;71:163–4.
Semeraro FF, Russo AA, Duse SS, et al. Retinal angiomatosis and cystoid macular oedema in Cogan’s syndrome. Optom Vis Sci. 2011;88:E1262–6.
Martinez-Osorio H, Fuentes-Paez G, Calonge M. Severe keratopathy in paediatric Cogan’s syndrome. Rheumatology. 2006;45:1576–7.
Zamir E, Pe’er J, Solomon A. Cogan syndrome with disfiguring lipid keratopathy. Arch Ophthalmol. 2004;122:1242–3.
Kondo Y, Ito S, Ohi Y, et al. Atypical Cogan’s Syndrome with Aortitis. Intern Med. 2009;48:1093–7.
Albayram MS, Wityk R, Yousem DM, Zinreich SJ. The cerebral angiographic findings in Cogan syndrome. AJNR Am J Neuroradiol. 2001;22:751–4.
Yaginuma A, Sakai T, Kohno H, et al. A case of atypical Cogan’s syndrome with posterior scleritis and uveitis. Jpn J Ophthalmol. 2009;53:659–61.
Baumann A, Helbling A, Oertle S, et al. Cogan’s syndrome: clinical evolution of deafness and vertigo in three patients. Eur Arch Otorhinolaryngol. 2004;262:45–9.
Scharl M, Frei P, Fried M, et al. Association between Cogan’s syndrome and inflammatory bowel disease: a case series. J Crohn’s Colitis. 2011;5:64–8.
Antonios N, Silliman S. Cogan syndrome. Neurologist. 2012;18:55–63.
Udayaraj UP, Hand MF, Shilliday IR, Smith WG. Renal involvement in Cogan’s syndrome. Nephrol Dial Transplant. 2004;19:2420–1.
Chen SI, Sahni J, Hart IK. Atypical Cogan’s syndrome presenting with bilateral acute glaucoma. Eye (London, England). 2004;18:328–29.
Balink H, Bruyn GAW. The role of PET/CT in Cogan’s syndrome. Clin Rheumatol. 2007;26:2177–9.
Brogan K, Eleftheriou D, Rajput K, et al. Tubulointerstitial nephritis, uveitis, hearing loss and vestibular failure: TINU-atypical Cogan’s overlap syndrome. Rheumatology. 2012;51:950–2.
Shibuya M, Fujio K, Morita K, et al. Successful treatment with tocilizumab in a case of Cogan’s syndrome complicated with aortitis. Mod Rheumatol. 2012;23:577–81.
Azami A, Maleki N, Kalantar Hormozi M, Tavosi Z. Case report. Case Rep Med. 2014:1–4. Available at: http://www-ncbi-nlm-nih-gov.ezproxy.hsc.usf.edu/pmc/articles/PMC3970326/pdf/CRIM2014-830831.pdf.
Erb N, Sinha A, Slaney PL, Rowe IF. Acute atrioventricular node block requiring cardiac pacing in Cogan’s syndrome. Rheumatology. 2003;42:1126–8.
Parra-García GD, Callejas-Rubio JL, Ríos-Fernández R, et al. Otolaryngologic manifestations of systemic vasculitis. Acta Otorrinolaringol (English Edition). 2012;63:303–10.
Migliori G, Battisti E, Pari M, et al. A shifty diagnosis: Cogan’s syndrome. A case report and review of the literature. Acta Otorhinolaryngol Ital. 2009;29:108–13.
Kanatani M, Nakamura R, Kurokawa K, et al. Hypopituitarism associated with Cogan’s syndrome; high-dose glucocorticoid therapy reverses pituitary swelling. Jpn J Med. 1991;30:164–9.
Van Doornum S, McColl G, Walter M, et al. Prolonged prodrome, systemic vasculitis, and deafness in Cogan’s syndrome. Ann Rheum Dis. 2001;60:69–71.
Boulinguez S, Bernard P, Bedane C, et al. Pyoderma gangrenosum complicating Cogan’s syndrome. Clin Exp Dermatol. 1998;23:286–9.
Lydon EJ, Barisoni L, Belmont HM. Cogan’s syndrome and development of ANCA-associated renal vasculitis after lengthy disease remission. Clin Exp Rheumatol. 2009;27:S144–S144.
Orsoni JG, Zavota L, Vincenti V, et al. Cogan syndrome in children: early diagnosis and treatment is critical to prognosis. Am J Ophthalmol. 2004;137:757–8.
Pellistri I, Mora P, Ponzin D, et al. Cogan syndrome: confocal microscopy assessment of corneal damage. Eur J Ophthalmol. 2010;20:504–8.
Dua HS, Azuara-Blanco A. Corneal allograft rejection: risk factors, diagnosis, prevention, and treatment. Indian J Ophthalmol. 1999;47:3–9.
Son HJ, Ulualp SO. Course of auditory impairment in Cogan’s syndrome. Am J Otolaryngol Head Neck Med Surg. 2009;30:65–8.
Gasparovic H, Djuric Z, Bosnic D, et al. Aortic root vasculitis associated with Cogan’s syndrome. ATS. 2011;92:340–1.
Stanek G, Strle F. Lyme borreliosis. Lancet. 2003;362:1639–47.
Beyea JA, Agrawal SK, Parnes LS. Recent advances in viral inner ear disorders. Curr Opin Otolaryngol Head Neck Surg. 2012;20:404–8.
Sharma A, Gnanapandithan K, Sharma K, Sharma S. Relapsing polychondritis: a review. Clin Rheumatol. 2013;32:1575–83.
Yoo JH, Chodosh J, Dana R. Relapsing polychondritis: systemic and ocular manifestations, differential diagnosis, management, and prognosis. Semin Ophthalmol. 2011;26:261–9.
Keser G, Direskeneli H, Aksu K. Management of Takayasu arteritis: a systematic review. Rheumatology. 2014;53:793–801.
Sakata VM, da Silva FT, Hirata CE, et al. Autoimmun Rev. 2014;13:550–5.
Weyn T, Haine S, Conraads V. Cogan’s syndrome with left main coronary artery occlusion. Cardiol J. 2009;16:573–6.
Fugate JE, Smith JH, Claassen DO. Bilateral cochlear enhancement in Cogan syndrome. Neurology. 2009;73:75.
Akpek EK, Uy HS, Christen W, et al. Severity of episcleritis and systemic disease association. Ophthalmology. 1999;106:729–31.
Inoue Y, Tomemori T, Suzuki S, et al. Low-dose oral methotrexate for the management of childhood Cogan’s syndrome: a case report. Clin Rheumatol. 2007;26:2201–3.
Ying Y-LM, Hirsch BE. Atypical Cogan’s syndrome: a case report. Am J Otolaryngol Head Neck Med Surg 2010;31:279–82.
Xie L, Cai Y, Bao X, Cao L. Leflunomide for the successful management of juvenile Cogan’s syndrome. Clin Rheumatol. 2009;28:1453–5.
Roat MI, Thoft RA, Thomson AW, et al. Treatment of Cogan’s syndrome with FK 506: a case report. Transpl Proc. 1991;23:3347.
Matteson EL, Fabry DA, Facer GW, et al. Open trial of methotrexate as treatment for autoimmune hearing loss. Arthritis Rheum. 2001;45:146–50.
Watanabe K, Nishimaki T, Yoshida M, et al. Atypical Cogan’s syndrome successfully treated with corticosteroids and pulse cyclophosphamide therapy. Fukushima J Med Sci. 2000;46:49–54.
Nussenblatt RB, Whitcup SM. Uveitis. Elsevier Health Sciences; 2010.
Touma Z, Nawwar R, Hadi U, et al. The use of TNF-α blockers in Cogan’s syndrome. Rheumatol Int. 2007;27:995–6.
Beccastrini E, Emmi G, Squatrito D, et al. Infliximab and Cogan’s syndrome. Clin Otolaryngol. 2010;35:441–2.
Bovo R, Ciorba A, Trevisi P, et al. Cochlear implant in Cogan syndrome. Acta Otolaryngol. 2011;131:494–7.
Kontorinis G, Giourgas A, Neuburger J, et al. Long-term evaluation of Cochlear implantation in Cogan syndrome. ORL. 2010;72:275–9.
Su JW, Low AHL, Tay KH, et al. Recurrent aortic aneurysms following thoracic aortic stent-graft repair in a patient with Cogan syndrome. J Endovasc Surg. 2006;13:779–82.
Kim JS, Park JB, Joo JC, et al. A case of Cogan’s syndrome with angina. Korean Circ J. 2010;40:680.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Chang, V. (2017). Cogan Syndrome. In: Papaliodis, G. (eds) Uveitis. Springer, Cham. https://doi.org/10.1007/978-3-319-09126-6_21
Download citation
DOI: https://doi.org/10.1007/978-3-319-09126-6_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-09125-9
Online ISBN: 978-3-319-09126-6
eBook Packages: MedicineMedicine (R0)